Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. NMDA-R encephalitis and MOG autoimmunity are most common, though other entities, including aquaporin-4 autoimmunity, CASPR2 autoimmunity, autoimmune GFAP astrocytopathy and paraneoplastic encephalomyelopathies, may also occur in children.
Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.
At MCL, we recommend testing in both serum and spinal fluid. Certain antibodies (i.e., NMDA) are more specifically detected in spinal fluid and not in serum. This is especially the case in children with autoimmune encephalitis. If testing is not performed on both specimen types, autoantibodies could be missed and patients could be mistreated.
Spinal Fluid
Container/Tube: Sterile vial
Specimen Volume: 4 mL
Serum
Container/Tube Preferred: Red top
Acceptable: Serum gel
Specimen Volume: 4 mL
Day(s) and Time(s) Test Performed
Monday through Friday; Varies
Analytic Time
5 days